31P NMR of phospholipid metabolites in prostate cancer and benign prostatic hyperplasia. - Wikidata - awgldk - TriplyDB

31P NMR of phospholipid metabolites in prostate cancer and benign prostatic hyperplasia.

31P NMR of phospholipid metabolites in prostate cancer and benign prostatic hyperplasia.

http://www.wikidata.org/entity/Q44673076

about

Molecular magnetic resonance imaging in cancer MRI at 7 Tesla and above: demonstrated and potential capabilities.A decade in prostate cancer: from NMR to metabolomics.High-resolution NMR spectroscopy of human body fluids and tissues in relation to prostate cancer.High-resolution (31) P echo-planar spectroscopic imaging in vivo at 7T.NMR-based metabolomics of prostate cancer: a protagonist in clinical diagnostics.Metabolomic Biomarkers of Prostate Cancer: Prediction, Diagnosis, Progression, Prognosis, and Recurrence.Phorbol ester stimulates ethanolamine release from the metastatic basal prostate cancer cell line PC3 but not from prostate epithelial cell lines LNCaP and P4E6.Quantitative (31)P HR-MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts.(31) P MR spectroscopic imaging of the human prostate at 7 T: T1 relaxation times, Nuclear Overhauser Effect, and spectral characterization.(31) P MR spectroscopic imaging combined with (1) H MR spectroscopic imaging in the human prostate using a double tuned endorectal coil at 7T.In vivo31P MR spectroscopic imaging of the human prostate at 7 T: Safety and feasibility

P2860

Q26782151-FDDE587A-EBF2-4BE2-870B-8E5B3C6FCFC4 Q30745387-07F4D5E4-53D7-4EDC-BD36-B182691C27CD Q37876681-4F222EC7-3C0E-4C6C-880A-791F0E09FB72 Q38119455-0E0773AA-99F1-46F3-BC3B-9C29D1757E8B Q38714478-443447BE-9502-4510-B853-A5C956C7C190 Q38767020-52DD8AA2-F39E-47CA-9F1A-EBAF56DAADC9 Q38838580-7528E5A3-ACA9-414C-8BAB-A2E3F9038C58 Q38964675-A4407E3C-6467-4D21-BAFA-74A944E47909 Q42441848-B2C3187C-BEE8-4E44-9A94-503FDA56CA8E Q51099040-DD57C23C-8C96-45F4-8D86-31C8FA8592C2 Q53652219-7E8B3D10-0E4E-42B9-9449-EA4AE3B4D835 Q57628144-59C249C0-9AEB-40DD-962A-336C1C056336

P2860

31P NMR of phospholipid metabolites in prostate cancer and benign prostatic hyperplasia.

http://www.wikidata.org/entity/Q44673076

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

31P NMR of phospholipid metabolites in prostate cancer and benign prostatic hyperplasia.

@en

31P NMR of phospholipid metabolites in prostate cancer and benign prostatic hyperplasia.

@nl

type

label

31P NMR of phospholipid metabolites in prostate cancer and benign prostatic hyperplasia.

@en

31P NMR of phospholipid metabolites in prostate cancer and benign prostatic hyperplasia.

@nl

prefLabel

31P NMR of phospholipid metabolites in prostate cancer and benign prostatic hyperplasia.

@en

31P NMR of phospholipid metabolites in prostate cancer and benign prostatic hyperplasia.

@nl

P1433

Q44673076-4EB6D6CA-D154-4546-85A4-A0F2F1213CB2

P1476

Q44673076-F4E94903-499C-4022-AA9A-1AF58F29C5A3

P2093

Q44673076-665CD8D1-B885-4451-BBB3-F533660B9A43

Q44673076-6A151981-F78F-4CB3-AF03-930119824D55

Q44673076-7531AA1E-4C76-4B81-80D4-F687C18E3036

Q44673076-EF3BA51E-D9B5-4349-B8B0-73E1DF809463

P2860

Q44673076-38A34640-7607-4C18-96E2-91578B212F12

Q44673076-4CA9BCDA-6EA1-4611-9CCA-1A0320A97321

Q44673076-5A6BC6A2-E7A1-44AB-A77D-A0F642D374EC

Q44673076-83F2FAA0-BA39-4B3B-A9CF-9B11A08D60C9

Q44673076-93A153B7-B2C7-45D6-9A44-E73B30E651E8

Q44673076-A2A0C7FE-09D4-4A4E-9027-7ABCD82A5F00

Q44673076-CC480E23-0ACA-4C37-B309-2A68146578B3

Q44673076-EF6DBDF4-6D4C-4272-B401-6CD30471DB8E

Q44673076-F039C205-6D1F-418C-A91C-3456FDAFB5AC

P304

Q44673076-D6838FD0-65CB-45A6-8D96-2CDC4BD183BB

P31

Q44673076-4CDD5944-F8F9-4112-A06F-D1135FD081FB

P356

Q44673076-3931488E-DC6C-491F-A6FB-1389A33474BA

P433

Q44673076-9C7F5678-1846-4834-AA16-D6F8BF9F600F

P478

Q44673076-9D665D17-C2A7-4053-A7EA-716033CE1C4C

P577

Q44673076-B1742B27-743E-4CD6-8D71-AD278BC7D44D

P5875

Q44673076-F982F43B-4E31-491E-8B03-293764CABBDC

P698

Q44673076-55CEEBE3-64D3-4A5E-A428-1FBEEAB3518B

P356

P1433

Magnetic Resonance in Medicine

P1476

31P NMR of phospholipid metabolites in prostate cancer and benign prostatic hyperplasia.

@en

P2093

Alex A Pappas

http://www.w3.org/2001/XMLSchema#string

Alex E Finkbeiner

http://www.w3.org/2001/XMLSchema#string

John C Holder

http://www.w3.org/2001/XMLSchema#string

Richard A Komoroski

http://www.w3.org/2001/XMLSchema#string

P2860

Tumour phospholipid metabolism.

Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis.

Proton spectroscopic imaging of the human prostate at 7 T.

Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy.

Advances in MR spectroscopy of the prostate.

Comparison of radiolabeled choline and ethanolamine as probe for cancer detection.

31P spectroscopy of the human prostate gland in vivo using a transrectal probe.

31P NMR spectroscopy of phospholipid metabolites in postmortem schizophrenic brain.

P-31 nuclear magnetic resonance analysis of brain: the perchloric acid extract spectrum.

P304

911-913

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MRM.22677

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47521459

http://www.w3.org/2001/XMLSchema#string

P698

20967792

http://www.w3.org/2001/XMLSchema#string